Lilly's Retatrutide Shows Significant Weight Loss in Type 2 Diabetes Patients | Retatrutide News

Eli Lilly's Retatrutide has shown potential for significant weight loss in Type 2 diabetes patients. Participants in the trials lost up to 60 pounds, ma...
Clinical Trials · October 11, 2026